Upgrade to SI Premium - Free Trial

BMO Capital Downgrades Abbvie (ABBV) to Underperform; 'Risk/Reward Skewed to the Downside'

January 29, 2018 7:34 AM
BMO Capital downgraded Abbvie (NYSE: ABBV) from Market Perform to Underperform with a price target of $95.00 (from $84.00).Analyst Alex ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Downgrades

Next Articles